Soludronate® Weekly
Soludronate® Weekly is indicated for the treatment of postmenopausal osteoporosis.
Alendronic acid reduces the risk of vertebral and hip fractures.
Access technical file Soludronate® Weekly 70 mg oral solution
Soludronate® Weekly
Content: 4 bottles of 100 mL.
Clear polyethylene terephthalate (PET) bottle with tamper evident seal and a low-density polyethylene liner in pack sizes of 4 bottles.
Last update: July 2024
The information contained in this area is directed exclusively to healthcare professionals with the capacity to prescribe or dispense medications.